These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9986924)

  • 1. Binding of the non-peptide vasopressin V1a receptor antagonist SR-49059 in the rat brain: an in vitro and in vivo autoradiographic study.
    Tribollet E; Raufaste D; Maffrand J; Serradeil-Le Gal C
    Neuroendocrinology; 1999 Feb; 69(2):113-20. PubMed ID: 9986924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoradiographic localization of vasopressin V1a receptors in the rat kidney using [3H]-SR 49059.
    Serradeil-Le Gal C; Raufaste D; Marty E; Garcia C; Maffrand JP; Le Fur G
    Kidney Int; 1996 Aug; 50(2):499-505. PubMed ID: 8840278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of [3H] SR 49059, a potent nonpeptide vasopressin V1a antagonist, to rat and human liver membranes.
    Serradeil-Le Gal C; Raufaste D; Marty E; Garcia C; Maffrand JP; Le Fur G
    Biochem Biophys Res Commun; 1994 Feb; 199(1):353-60. PubMed ID: 8123034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, tolerability, and pharmacokinetics of SR 49059, a V1a vasopressin receptor antagonist, after repeated oral administration in healthy volunteers.
    Brouard R; Laporte V; Serradeil Le Gal C; Pignol R; Jang H; Donat F; Lockwood G; Fournie D; Dreux F
    Adv Exp Med Biol; 1998; 449():455-65. PubMed ID: 10026839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cells.
    Serradeil-Le Gal C; Bourrié B; Raufaste D; Carayon P; Garcia C; Maffrand JP; Le Fur G; Casellas P
    Biochem Pharmacol; 1994 Feb; 47(4):633-41. PubMed ID: 8129742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.
    Serradeil-Le Gal C; Wagnon J; Garcia C; Lacour C; Guiraudou P; Christophe B; Villanova G; Nisato D; Maffrand JP; Le Fur G
    J Clin Invest; 1993 Jul; 92(1):224-31. PubMed ID: 8392086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells.
    Serradeil-Le Gal C; Herbert JM; Delisee C; Schaeffer P; Raufaste D; Garcia C; Dol F; Marty E; Maffrand JP; Le Fur G
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H404-10. PubMed ID: 7840290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells.
    Tahara A; Saito M; Sugimoto T; Tomura Y; Wada K; Kusayama T; Tsukada J; Ishii N; Yatsu T; Uchida W; Tanaka A
    Br J Pharmacol; 1998 Dec; 125(7):1463-70. PubMed ID: 9884074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature.
    Ostrowski NL; Lolait SJ; Young WS
    Endocrinology; 1994 Oct; 135(4):1511-28. PubMed ID: 7925112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.
    Serradeil-Le Gal C; Lacour C; Valette G; Garcia G; Foulon L; Galindo G; Bankir L; Pouzet B; Guillon G; Barberis C; Chicot D; Jard S; Vilain P; Garcia C; Marty E; Raufaste D; Brossard G; Nisato D; Maffrand JP; Le Fur G
    J Clin Invest; 1996 Dec; 98(12):2729-38. PubMed ID: 8981918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]-SR 27897B: a selective probe for autoradiographic labelling of CCK-A receptors in the brain.
    Zajac JM; Gully D; Maffrand JP
    J Recept Signal Transduct Res; 1996; 16(1-2):93-113. PubMed ID: 8771533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin anti-idiotypic antibody staining in the rat brain: colocalization with [35S] [pGlu4, Cyt6]AVP(4-9) binding sites.
    Jurzak M; Fahrenholz F; Gerstberger R
    J Neuroendocrinol; 1993 Oct; 5(5):523-31. PubMed ID: 8680420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed.
    Heinemann A; Horina G; Stauber RE; Pertl C; Holzer P; Peskar BA
    Br J Pharmacol; 1998 Nov; 125(6):1120-7. PubMed ID: 9863637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic localization of V1 vasopressin binding sites in rat brain and kidney.
    Gerstberger R; Fahrenholz F
    Eur J Pharmacol; 1989 Aug; 167(1):105-16. PubMed ID: 2528467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [H]-SR 121463.
    Serradeil-Le Gal C; Raufaste D; Double-Cazanave E; Guillon G; Garcia C; Pascal M; Maffrand JP
    Kidney Int; 2000 Oct; 58(4):1613-22. PubMed ID: 11012895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the binding sites of the SR49059 nonpeptide antagonist into the V1a vasopressin receptor using sulfydryl-reactive ligands and cysteine mutants as chemical sensors.
    Tahtaoui C; Balestre MN; Klotz P; Rognan D; Barberis C; Mouillac B; Hibert M
    J Biol Chem; 2003 Oct; 278(41):40010-9. PubMed ID: 12869559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel, linear radioiodinated vasopressin antagonist: an excellent radioligand for vasopressin V1a receptors.
    Barbeis C; Balestre MN; Jard S; Tribollet E; Arsenijevic Y; Dreifuss JJ; Bankowski K; Manning M; Chan WY; Schlosser SS
    Neuroendocrinology; 1995 Aug; 62(2):135-46. PubMed ID: 8584113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V
    Taveau C; Chollet C; Bichet DG; Velho G; Guillon G; Corbani M; Roussel R; Bankir L; Melander O; Bouby N
    Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E127-E135. PubMed ID: 27998960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]arginine vasopressin binding to rat brain: a homogenate and autoradiographic study.
    Lawrence JA; Poulin P; Lawrence D; Lederis K
    Brain Res; 1988 Apr; 446(2):212-8. PubMed ID: 3370487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central vasopressin V1A receptor blockade alters patterns of cellular activation and prevents glucocorticoid habituation to repeated restraint stress exposure.
    Gray M; Innala L; Viau V
    Int J Neuropsychopharmacol; 2014 Dec; 17(12):2005-15. PubMed ID: 24913767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.